会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • GLP-1 Derivatives
    • GLP-1衍生物
    • US20140303083A1
    • 2014-10-09
    • US14343152
    • 2012-09-06
    • Jesper LauPaw BlochJacob KofoedPatrick William Garibay
    • Jesper LauPaw BlochJacob KofoedPatrick William Garibay
    • C07K14/605
    • C07K14/605A61K38/00A61K38/26
    • The invention relates to a derivative of a GLP-1 peptide, which peptide has two Lys residues, namely a first and a second Lys residue, and a maximum of eight amino acid changes as compared to GLP-1(7-37) (SEQ ID NO: 3), which derivative comprises two protracting moieties attached to the epsilon amino group of said first and second Lys residue, respectively, via a linker, wherein the protracting moiety is selected from Chem. 15: HOOC—(CH2)x-CO—*, and Chem. 16: HOOC—C6H4-O—(CH2)y-CO—*, in which x is an integer in the range of 10-16, and y is an integer in the range of 8-12; and the linker comprises a first linker element *—NH—CH(CH2OH)—CO—*. A preferred linker is g Glu-Ser-Ser-Gly-Ser-Ser-Gly (SEQ ID NO: 2). The derivative of the invention has a very good potency, and a very good binding to the GLP-1 receptor. The invention also relates to the pharmaceutical use of the derivative, for example in the treatment and/or prevention of all forms of diabetes and related diseases.
    • 本发明涉及GLP-1肽的衍生物,该肽与GLP-1(7-37)(SEQ)相比具有两个Lys残基,即第一和第二Lys残基,最多八个氨基酸变化 SEQ ID NO:3),该衍生物分别包含通过接头分别连接到所述第一和第二Lys残基的ε氨基的两个伸长部分,其中伸长部分选自Chem。 15:HOOC-(CH 2)x-CO- *,和Chem。 16:HOOC-C6H4-O-(CH2)y-CO- *,其中x是10-16的整数,y是8-12的整数; 并且连接体包含第一连接体元件* -NH-CH(CH 2 OH)-CO- *。 优选的接头是g Glu-Ser-Ser-Gly-Ser-Ser-Gly(SEQ ID NO:2)。 本发明的衍生物具有非常好的效力,并且与GLP-1受体具有非常好的结合。 本发明还涉及衍生物的药物用途,例如用于治疗和/或预防所有形式的糖尿病和相关疾病。
    • 8. 发明申请
    • Novel Glp-1 Derivatives
    • 新型Glp-1衍生物
    • US20070203058A1
    • 2007-08-30
    • US10572348
    • 2004-09-17
    • Jesper LauThomas HansenKjeld MadsenPaw BlochFlorencio DorwaldNils Johansen
    • Jesper LauThomas HansenKjeld MadsenPaw BlochFlorencio DorwaldNils Johansen
    • A61K38/26
    • C07K14/605A61K38/00A61K38/26A61K47/54A61K47/542A61K47/60C07K14/001
    • Novel polypeptide derivatives having protracted profile of action. The present invention relates to a compound which comprises a therapeutic polypeptide linked to an albumin binding residue via a hydrophilic spacer. The present invention also relates to a compound which comprises a therapeutic polypeptide linked to an albumin binding residue via a hydrophilic spacer that separates the polypeptide and the albumin binding residue with a chemical moiety comprising at least 5 non-hydrogen atoms where 30-50% of these atoms are either N or O. In one embodiment of this invention the spacer is defined as —(CH2)lD[(CH2)nE]m(CH2)pQq-, wherein l, m and n independently are 1-20 and p is 0-10, Q is -Z-(CH2)lD[(CH2)nG]m(CH2)p—, q is an integer in the range from 0 to 5, each D, E and G independently are selected from —O—, NR3—, —N(COR4)—, —PR5(O)—, and —P(OR6)(O)—, wherein R3, R4, R5, and R6 independently represent hydrogen or C1-6-alky, Z is selected from —C(O)NH—, —C(O)NHCH2—, —OC(O)NH—, —C(O)NHCH2CH2—, —C(O)CH2—, —C(O)CH═CH—, —(CH2)s—, —C(O)—, —C(O)O— or —NHC(O)—, wherein s is 0 or 1.
    • 新型多肽衍生物具有延长的作用特征。 本发明涉及包含通过亲水间隔物与白蛋白结合残基连接的治疗性多肽的化合物。 本发明还涉及一种化合物,其包含通过亲水间隔物与白蛋白结合残基连接的治疗性多肽,其将多肽和白蛋白结合残基与包含至少5个非氢原子的化学部分分开,其中30-50% 这些原子是N或O.在本发明的一个实施方案中,间隔基被定义为 - (CH 2)2 D [(CH 2)2 (CH 2)n) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 其中l,m和n独立地是1-20,p是0-10,Q是-Z-(CH 2)2 D [(CH 2) (CH 2) - - - - - - - - - - - - - - - - 范围为0至5,每个D,E和G各自独立地选自-O-,NR 3 - , - N(COR 4 - ) - , - PR